STOCK TITAN
  1. Home
  2. News
  3. VERO

Venus Concept Inc - VERO STOCK NEWS

Welcome to our dedicated news page for Venus Concept (Ticker: VERO), a resource for investors and traders seeking the latest updates and insights on Venus Concept.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Venus Concept's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Venus Concept's position in the market.

News
Venus Concept to Release Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) to release Q4 and fiscal year 2023 financial results on April 1, 2024. Conference call scheduled for discussion. Webcast available for investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.61%
Tags
earnings
-
News
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 13th
Rhea-AI Summary
Venus Concept Inc. will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference from February 13th – 14th. The Company's management will engage in virtual investor meetings, with no formal presentation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.5%
Tags
conferences
-
News
Venus Concept Inc. Announces Review of Strategic Alternatives
Rhea-AI Summary
Venus Concept Inc. (VERO) is exploring strategic alternatives to maximize shareholder value, including financings, mergers, sales of assets, and more. The company has retained Canaccord Genuity LLC as its financial advisor for this process. There is no guarantee of any transaction, and no set timeline for completion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Venus Concept Inc. Announces Issuance of $2.0M of Convertible Notes
Rhea-AI Summary
Venus Concept, Inc. announced the issuance of new secured convertible notes to EW Healthcare Partners, L.P. and one of its affiliates in an aggregate principal amount of $2.0 million. The notes have a maturity date of December 9, 2025, an annual interest rate of 90-day Adjusted SOFR + 8.5%, and are convertible into shares of common stock of the Company at an initial conversion price of $1.251 per share. This financing provides additional liquidity to support ongoing operations and execution of the Company's near-to-intermediate term strategic turnaround objectives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
none
-
News
Venus Concept Launches Venus Prime
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) has announced the launch of Venus Prime, a structured in-house financing program for new customers in North America. The program offers competitive financing rates and payment flexibility for purchasing aesthetic medical devices, as well as a technology upgrade program. Venus Prime aims to support high-quality customers who may not qualify for traditional third-party financing due to current tight lending practices. This initiative, along with the company's focus on cash sales, is part of their effort to achieve cashflow breakeven.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.43%
Tags
none
-
News
Venus Concept Announces New International Distributors in the United Kingdom and India to Continue Global Growth
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) has announced the expansion of its international distributor network with the signing of two new exclusive partnerships: Core Aesthetics Skin & Laser Limited in the United Kingdom and Spectra Medical Systems in India. The company aims to drive international growth through strong distributor partnerships, focusing on high-growth markets. Core Aesthetics brings years of industry experience and a reputation as a trusted distributor, while Spectra is a leading medical equipment distributor with extensive experience in the aesthetic industry. This expansion represents an important step for Venus Concept's strategic growth plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags
none
News
Venus Concept Announces Third Quarter of Fiscal Year 2023 Financial Results
Rhea-AI Summary
Venus Concept Inc. (NASDAQ: VERO) announced financial results for the three and nine months ended September 30, 2023. Total revenue was $17.6 million, down 18% year-over-year. Operating expenses decreased by 24%. GAAP net loss was $9.1 million, down 38% year-over-year. The Company established a medical advisory board for AI, received FDA clearance for Venus Versa Pro System, restructured debt, appointed a new President and COO, and launched Venus Aesthetic Intelligence. Revenue guidance for 2023 is $80-82 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
earnings
-
News
Venus Concept Launches Venus Versa Pro, its new multi-application platform for face and body treatments
Rhea-AI Summary
Venus Concept Inc. announces the commercial launch of its new multi-application platform Venus Versa Pro in the United States. The platform supports 10 different applicators for various aesthetic conditions and incorporates advanced technologies for skin remodeling and resurfacing. The launch reflects the company's commitment to delivering innovative solutions and introduces the Venus Aesthetic Intelligence rebrand. Venus Versa Pro is expected to contribute to revenue growth in 2024 and beyond.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.08%
Tags
none
-
News
Venus Concept Launches New “Venus Aesthetic Intelligence” Branding and Updated “Venus.ai” Website to Reflect New Vision for the Company
Rhea-AI Summary
Venus Concept announces company-wide rebranding initiative to reflect a new strategic vision and enhanced focus on emerging technologies in aesthetics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.04%
Tags
AI
News
Venus Concept Inc. Appoints Dr. Hemanth Varghese as President and Chief Operating Officer and Industry Veteran to Lead International Operations
Rhea-AI Summary
Venus Concept promotes Dr. Hemanth Varghese to President and COO, and hires Kirk Gunhus as VP and GM of International Sales and Marketing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.74%
Tags
management
Stock VERO logo
Venus Concept Inc

Nasdaq:VERO

VERO Rankings

N/A Ranked by Market Cap
#4034 Ranked by Stock Gains
N/A Ranked by Dividends

VERO Stock Data

4.31M
2.57M
8.02%
47.85%
0.44%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
Canada
Toronto

About VERO

venus concept is a leader in the global medical aesthetic market, pairing best-in-class technology with the first and only true subscription model in the industry. our goal is to help both new and established practices succeed in this growing field. we understand the challenges of breaking into and being successful in the aesthetics industry, and that’s why we’re changing the game with an innovative solution. the secret is in our industry-unique subscription model. in partnering with venus concept, aesthetic professionals worldwide gain access to never-before-seen business features such as the most comprehensive warranty program, unmatched marketing support, continuous clinical education, valuable practice enhancement programs, and more. together with this business model, our collection of aesthetic systems—including venus versa™, venus legacy™, venus velocity™, venus viva™, venus freeze plus™, and venus skin™—are setting higher industry standards and improving the quality of life for